Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:09 am
Author: Getaka|Social: XLinkedIn

J B Chemicals & Pharmaceuticals Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹1,685.26Overvalued by 16.11%vs CMP ₹2,009.00

P/E (42.8) × ROE (20.1%) × BV (₹243.00) × DY (0.77%)

₹844.27Overvalued by 57.98%vs CMP ₹2,009.00
MoS: -138% (Negative)Confidence: 63/100 (Moderate)Models: 1 Fair, 8 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹1,923.0322%Fair (-4.3%)
Graham NumberEarnings₹513.5116%Over (-74.4%)
Earnings PowerEarnings₹282.7513%Over (-85.9%)
DCFCash Flow₹917.4913%Over (-54.3%)
Net Asset ValueAssets₹237.077%Over (-88.2%)
EV/EBITDAEnterprise₹748.159%Over (-62.8%)
Earnings YieldEarnings₹482.307%Over (-76%)
ROCE CapitalReturns₹633.569%Over (-68.5%)
Revenue MultipleRevenue₹366.075%Over (-81.8%)
Consensus (9 models)₹844.27100%Overvalued
Key Drivers: Wide model spread (₹237–₹1,923) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 14.1%

*Investments are subject to market risks

Investment Snapshot

73
J B Chemicals & Pharmaceuticals Ltd scores 73/100 (Strong)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health88/100 · Strong
ROCE 25.8% ExcellentROE 20.1% ExcellentD/E 0.01 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money55/100 · Moderate
FII holding down -3.22% (6mo) SellingDII holding up 3.09% MF buyingPromoter increased by 1.23% Positive
Earnings Quality65/100 · Strong
OPM expanding (22% → 26%) Improving
Quarterly Momentum68/100 · Strong
Revenue (4Q): +9% YoY GrowingProfit (4Q): +18% YoY Positive
Industry Rank75/100 · Strong
P/E 42.8 vs industry 53.8 In-lineROCE 25.8% vs industry 16.4% Above peersROE 20.1% vs industry 15.2% Above peers3Y sales CAGR: 17% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:09 am

Market Cap 32,253 Cr.
Current Price 2,009
Intrinsic Value₹844.27
High / Low 2,195/1,303
Stock P/E42.8
Book Value 243
Dividend Yield0.77 %
ROCE25.8 %
ROE20.1 %
Face Value 1.00
PEG Ratio3.03

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for J B Chemicals & Pharmaceuticals Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
J B Chemicals & Pharmaceuticals Ltd 32,253 Cr. 2,009 2,195/1,30342.8 2430.77 %25.8 %20.1 % 1.00
Ajanta Pharma Ltd 35,192 Cr. 2,817 3,228/2,02234.7 3450.99 %32.4 %24.9 % 2.00
Gland Pharma Ltd 28,107 Cr. 1,706 2,131/1,20023.7 6101.06 %15.8 %11.6 % 1.00
Ipca Laboratories Ltd 38,264 Cr. 1,508 1,624/1,16836.2 2930.27 %14.7 %12.8 % 1.00
Glaxosmithkline Pharmaceuticals Ltd 39,458 Cr. 2,329 3,516/2,21839.2 1011.80 %63.2 %46.9 % 10.0
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of J B Chemicals & Pharmaceuticals Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 7937628968828458621,0041,0019639491,0941,0851,065
Expenses 618599664638621664724730709723793775769
Operating Profit 175164232244223198280271255226301310296
OPM % 22%21%26%28%26%23%28%27%26%24%28%29%28%
Other Income 3568717610814151518
Interest 81412101296231112
Depreciation 28323132344141424246434445
Profit before tax 141122194209184165240237218193272279267
Tax % 25%28%27%28%27%23%26%26%25%25%25%26%26%
Net Profit 10688142151134126177175162146202208198
EPS in Rs 6.865.669.199.728.618.1311.3911.2410.459.3612.9713.2712.63

Last Updated: February 5, 2026, 10:38 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 3:46 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 1,0221,1441,2101,3441,4081,6431,7752,0432,4243,1493,4843,9184,193
Expenses 8749641,0041,1121,1911,3371,3971,4821,8812,4542,5872,8863,060
Operating Profit 1481802062322183063785605436968971,0321,133
OPM % 14%16%17%17%15%19%21%27%22%22%26%26%27%
Other Income -271158503741411123910373863
Interest 67115353753644126
Depreciation 283941475756666973114138171179
Profit before tax 871462122301942873495975055557528871,011
Tax % 30%31%23%20%28%32%22%25%24%26%26%26%
Net Profit 62100163184139194272449386410553660754
EPS in Rs 3.635.929.5810.858.2812.0517.6028.9824.9326.4835.6142.3748.23
Dividend Payout % 41%118%26%5%12%21%31%28%33%34%34%37%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)61.29%63.00%12.88%-24.46%39.57%40.21%65.07%-14.03%6.22%34.88%19.35%
Change in YoY Net Profit Growth (%)0.00%1.71%-50.12%-37.34%64.02%0.64%24.87%-79.10%20.25%28.66%-15.53%

J B Chemicals & Pharmaceuticals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:13%
5 Years:17%
3 Years:17%
TTM:12%
Compounded Profit Growth
10 Years:21%
5 Years:20%
3 Years:21%
TTM:17%
Stock Price CAGR
10 Years:30%
5 Years:34%
3 Years:23%
1 Year:-11%
Return on Equity
10 Years:17%
5 Years:20%
3 Years:19%
Last Year:20%

Last Updated: September 5, 2025, 8:10 am

Balance Sheet

Last Updated: December 4, 2025, 1:28 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 17171717171615151515161616
Reserves 1,0269781,1671,3471,4251,4641,4201,7942,1192,4652,9083,4183,790
Borrowings 931271934929262945555723782819
Other Liabilities 215365270262294286349376412495687804887
Total Liabilities 1,3511,4871,6481,6741,7651,7921,8142,2312,6013,5473,9884,2654,712
Fixed Assets 3113294406796406216516341,2771,9012,0041,9681,977
CWIP 46551354171516261955766332
Investments 50055247941143445740367813206388345519
Other Assets 4945525945806746997438941,2931,3851,5191,8892,184
Total Assets 1,3511,4871,6481,6741,7651,7921,8142,2312,6013,5473,9884,2654,712

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + -14127140201123194276315170626801902
Cash from Investing Activity + -142-112-26-45-21-2824-2312-962-404-296
Cash from Financing Activity + 12-1-100-184-60-156-306-87-138357-385-580
Net Cash Flow -1441315-284311-6-334201127
Free Cash Flow -7456-634894153205315-529-138540783
CFO/OP 10%91%94%107%75%85%97%81%56%104%104%107%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow55.0053.0013.00183.00189.00280.00349.00515.00488.00124.00519.00-27.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 848482727868717084677276
Inventory Days 120122146138145149159181178134155147
Days Payable 54637168757297979775110114
Cash Conversion Cycle 150143158142148146133153164127117109
Working Capital Days 7016387593918191122815579
ROCE %13%13%15%14%11%18%23%33%23%22%25%26%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Jan 2026
Promoters 53.91%53.86%53.83%53.78%53.77%53.74%53.66%47.84%47.73%47.56%47.55%48.78%
FIIs 9.53%10.05%10.35%11.06%12.17%13.63%14.64%18.30%17.77%15.31%14.88%14.55%
DIIs 18.65%18.58%18.53%18.38%17.61%16.81%16.40%18.71%19.62%22.83%23.35%22.71%
Government 0.00%0.00%0.00%0.01%0.00%0.01%0.00%0.00%0.00%0.00%0.00%0.00%
Public 17.90%17.50%17.27%16.78%16.42%15.80%15.29%15.13%14.87%14.31%14.21%13.94%
No. of Shareholders 55,96560,81763,23063,89266,95362,74362,08163,94870,06471,95769,33868,966

Shareholding Pattern Chart

No. of Shareholders

J B Chemicals & Pharmaceuticals Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Kotak Midcap Fund 4,816,878 1.53 900.52N/AN/AN/A
Axis Small Cap Fund 2,984,782 2.19 558.012,207,4752025-12-08 05:55:3735.21%
Canara Robeco Small Cap Fund 1,353,805 2 253.09790,0682025-12-08 05:55:3771.35%
Franklin India Small Cap Fund 1,316,741 1.93 246.161,448,7232026-02-22 13:50:45-9.11%
Axis ELSS Tax Saver Fund 1,087,630 0.62 203.33N/AN/AN/A
Nippon India Pharma Fund 999,649 2.37 186.881,486,8682025-12-08 04:19:42-32.77%
Nippon India Small Cap Fund 991,107 0.28 185.29937,8722025-12-08 05:55:375.68%
Axis Midcap Fund 984,875 0.6 184.12N/AN/AN/A
Nippon India Multi Cap Fund 898,827 0.34 168.04949,8342025-12-15 04:02:53-5.37%
Franklin India Large & Mid Cap Fund 767,185 4.08 143.43N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.002.002.002.00
Basic EPS (Rs.) 42.4535.6653.0049.8657.96
Diluted EPS (Rs.) 41.5634.8552.3449.8657.96
Cash EPS (Rs.) 53.3644.5267.7759.3566.92
Book Value[Excl.RevalReserv]/Share (Rs.) 220.54188.36320.55276.73234.65
Book Value[Incl.RevalReserv]/Share (Rs.) 220.54188.36320.55276.73234.65
Revenue From Operations / Share (Rs.) 251.67224.50407.00313.69264.29
PBDIT / Share (Rs.) 68.7460.1991.2075.4087.06
PBIT / Share (Rs.) 57.7651.2876.4266.0078.17
PBT / Share (Rs.) 57.0048.4271.7665.3377.23
Net Profit / Share (Rs.) 42.3735.6152.9949.9558.04
NP After MI And SOA / Share (Rs.) 42.3735.6152.9749.8657.96
PBDIT Margin (%) 27.3126.8122.4024.0332.93
PBIT Margin (%) 22.9422.8418.7721.0329.57
PBT Margin (%) 22.6421.5617.6320.8229.22
Net Profit Margin (%) 16.8315.8613.0115.9221.95
NP After MI And SOA Margin (%) 16.8315.8613.0115.8921.93
Return on Networth / Equity (%) 19.2118.9016.5218.0524.75
Return on Capital Employeed (%) 24.6925.4519.7122.9331.91
Return On Assets (%) 15.4313.8311.5314.7720.01
Long Term Debt / Equity (X) 0.000.010.150.000.00
Total Debt / Equity (X) 0.000.120.220.010.01
Asset Turnover Ratio (%) 0.940.921.020.910.94
Current Ratio (X) 3.042.132.763.324.50
Quick Ratio (X) 2.201.561.982.253.49
Inventory Turnover Ratio (X) 7.601.751.871.731.96
Dividend Payout Ratio (NP) (%) 35.9328.4031.1333.0916.38
Dividend Payout Ratio (CP) (%) 28.5322.7224.3327.8414.21
Earning Retention Ratio (%) 64.0771.6068.8766.9183.62
Cash Earning Retention Ratio (%) 71.4777.2875.6772.1685.79
Interest Coverage Ratio (X) 91.2421.0719.57113.7992.91
Interest Coverage Ratio (Post Tax) (X) 57.2413.4712.3776.3962.94
Enterprise Value (Cr.) 25138.2825860.2415719.7612145.749693.57
EV / Net Operating Revenue (X) 6.427.424.995.014.75
EV / EBITDA (X) 23.4927.6822.2820.8414.41
MarketCap / Net Operating Revenue (X) 6.457.354.845.024.74
Retention Ratios (%) 64.0671.5968.8666.9083.61
Price / BV (X) 7.368.766.155.705.35
Price / Net Operating Revenue (X) 6.457.354.845.024.74
EarningsYield 0.020.020.020.030.04

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

J B Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/12/1976 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24390MH1976PLC019380 and registration number is 019380. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 3722.92 Cr. and Equity Capital is Rs. 15.57 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsNeelam Centre, 'B' Wing, 4th floor, Mumbai Maharashtra 400030Contact not found
Management
NamePosition Held
Mr. Arun DuggalChairman & Ind.Director
Mr. Nikhil ChopraWholeTime Director & CEO
Mr. Prashant KumarNon Executive Director
Mr. Gaurav TrehanNon Executive Director
Mr. Akshay TannaNon Executive Director
Mr. Sumit BoseIndependent Director
Ms. Padmini Khare KaickerIndependent Director
Mr. Ashwani Kumar PuriIndependent Director

FAQ

What is the intrinsic value of J B Chemicals & Pharmaceuticals Ltd and is it undervalued?

As of 15 April 2026, J B Chemicals & Pharmaceuticals Ltd's intrinsic value is ₹844.27, which is 57.98% lower than the current market price of ₹2,009.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (20.1 %), book value (₹243), dividend yield (0.77 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of J B Chemicals & Pharmaceuticals Ltd?

J B Chemicals & Pharmaceuticals Ltd is trading at ₹2,009.00 as of 15 April 2026, with a FY2026-2027 high of ₹2,195 and low of ₹1,303. The stock is currently near its 52-week high. Market cap stands at ₹32,253 Cr..

How does J B Chemicals & Pharmaceuticals Ltd's P/E ratio compare to its industry?

J B Chemicals & Pharmaceuticals Ltd has a P/E ratio of 42.8, which is below the industry average of 53.84. This is broadly in line with or below the industry average.

Is J B Chemicals & Pharmaceuticals Ltd financially healthy?

Key indicators for J B Chemicals & Pharmaceuticals Ltd: ROCE of 25.8 % indicates efficient capital utilization; ROE of 20.1 % shows strong shareholder returns. Dividend yield is 0.77 %.

Is J B Chemicals & Pharmaceuticals Ltd profitable and how is the profit trend?

J B Chemicals & Pharmaceuticals Ltd reported a net profit of ₹660 Cr in Mar 2025 on revenue of ₹3,918 Cr. Compared to ₹386 Cr in Mar 2022, the net profit shows an improving trend.

Does J B Chemicals & Pharmaceuticals Ltd pay dividends?

J B Chemicals & Pharmaceuticals Ltd has a dividend yield of 0.77 % at the current price of ₹2,009.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in J B Chemicals & Pharmaceuticals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports